Health
Results: 169-180 of 6681

European Commission (EC) Approves Henlius and Organon’s BILDYOS® (denosumab) and BILPREVDA® (denosumab), Biosimilars to PROLIA (denosumab) and XGEVA (denosumab), Respectively

New YouGov data finds 1 in 3 Brits may be at risk of B12 deficiency - but most have no idea. Many mistake symptoms for stress or ageing, says Nature Provides

Setting the Standard: AMRA Medical Recognized as one of TIME Magazine’s ‘World’s Top HealthTech Companies’
